Literature DB >> 2293428

Seroepidemiological survey of Mediterranean spotted fever in an endemic area ('Vallés Occidental', Barcelona, Spain).

E Espejo-Arenas1, B Font-Creus, M D Alegre-Segura, F Segura-Porta, F Bella-Cueto.   

Abstract

A seroepidemiological survey of Mediterranean spotted fever was carried out in the region of 'Vallés Occidental', Barcelona (Spain). The prevalence of antibodies to Rickettsia conorii in human beings and dogs was determined by indirect immunofluorescence. In 200 samples of sera from subjects without former history of boutonneuse fever, an overall prevalence of antibodies to R. conorii of 11.6% was found. Seropositivity was significantly higher in the age group greater than 50 years. A significant correlation between seropositivity and habitat, social status, contact with dogs or risky practices was not found. In 48 sera from subjects with a history of Mediterranean spotted fever in the previous 10 years, the overall prevalence of antibodies was 68.7%, being 56.2% among those individuals who had suffered from the disease between 5 and 10 years earlier. In 103 dog serum samples collected during the summer, seropositivity was 36.8%. Positive sera were only detected in 1 of the 97 samples collected in winter, which suggests a relatively short duration of the canine immune response after contact with R. conorii.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2293428

Source DB:  PubMed          Journal:  Trop Geogr Med        ISSN: 0041-3232


  10 in total

1.  Prevalence of antibodies to spotted fever group rickettsiae in the region of Split (southern Croatia).

Authors:  Volga Punda-Polić; Zorana Klismanić; Vesna Capkun
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

2.  Serological evidence of human infection with rickettsial strain Bar29 in Catalonia, northeastern Spain.

Authors:  N Cardeñosa; M M Nogueras; B Font; F Segura; T Muñoz; I Sanfeliu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-08       Impact factor: 3.267

3.  Isolation and identification of Rickettsia massiliae from Rhipicephalus sanguineus ticks collected in Arizona.

Authors:  Marina E Eremeeva; Elizabeth A Bosserman; Linda J Demma; Maria L Zambrano; Dianna M Blau; Gregory A Dasch
Journal:  Appl Environ Microbiol       Date:  2006-08       Impact factor: 4.792

4.  Phenotypic and genotypic characterization of spotted fever group Rickettsiae isolated from Catalan Rhipicephalus sanguineus ticks.

Authors:  L Beati; V Roux; A Ortuño; J Castella; F S Porta; D Raoult
Journal:  J Clin Microbiol       Date:  1996-11       Impact factor: 5.948

5.  Antigens of Rickettsia conorii recognized by seropositive healthy people from Salamanca (central-west Spain).

Authors:  J I Herrero-Herrero; R Ruiz-Beltrán; D H Walker
Journal:  Eur J Epidemiol       Date:  1993-01       Impact factor: 8.082

6.  Seroepidemiology of rickettsial infections in Morocco.

Authors:  M Meskini; L Beati; A Benslimane; D Raoult
Journal:  Eur J Epidemiol       Date:  1995-12       Impact factor: 8.082

7.  Antibodies to Rickettsia conorii in dogs: seasonal differences.

Authors:  E Espejo; M D Alegre; B Font; A Font; F Segura; F Bella
Journal:  Eur J Epidemiol       Date:  1993-05       Impact factor: 8.082

8.  Prevalence of antibodies to spotted fever group rickettsiae in human beings and dogs from and endemic area of mediterranean spotted fever in Catalonia, Spain.

Authors:  F Segura-Porta; G Diestre-Ortin; A Ortuño-Romero; I Sanfeliu-Sala; B Font-Creus; T Muñoz-Espin; E M de Antonio; J Casal-Fábrega
Journal:  Eur J Epidemiol       Date:  1998-06       Impact factor: 8.082

9.  Canine seroprevalence of Rickettsia conorii infection (Mediterranean spotted fever) in Castilla y León (northwest Spain).

Authors:  S Delgado; P Cármenes
Journal:  Eur J Epidemiol       Date:  1995-10       Impact factor: 8.082

10.  Prevalence of antibodies to Rickettsia conorii in human beings and dogs from Catalonia: a 20-year perspective.

Authors:  E Espejo; M Andrés; J Pérez; J Prat; C Guerrero; M T Muñoz; M D Alegre; J Lite; F Bella
Journal:  Epidemiol Infect       Date:  2016-02-22       Impact factor: 4.434

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.